MINDY ENYART: Open Payments
NPI 1376174755 · WESTFIELD, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$443 in 22 payments from 10 companies in 2025. Trend: 2023 $168 · 2024 $152 · 2025 $443
Food & beverage: $443
| Company | Payments | Amount |
|---|---|---|
| Biogen, Inc. | 7 | $159 |
| MAYNE PHARMA COMMERCIAL LLC | 4 | $65 |
| Exeltis, USA Inc. | 3 | $61 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $34 |
| Organon LLC | 1 | $23 |
| MILLICENT US INC | 1 | $22 |
| Astellas Pharma US Inc | 1 | $21 |
| CooperSurgical, Inc. | 1 | $21 |
| Ethicon US, LLC | 1 | $19 |
| Hologic Sales and Service, LLC | 1 | $18 |
Products named: ZURZUVAE, SLYND, NEXPLANON, INTRAROSA, Veozah, Paragard T 380A, VISTASEAL, Sonata Sonography-Guided Transcervical Fibroid Ablation System.
Industry payments across IN — which companies pay providers there.
